Stability testing of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine: a translational study in UK vaccination centres
Open Access
- 13 September 2021
- journal article
- Published by Portico in BMJ Open Science
- Vol. 5 (1), e100203
- https://doi.org/10.1136/bmjos-2021-100203
Abstract
The roll-out of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine has brought many logistical challenges, such as the absence of comprehensive stability data leading to strict handling instructions during dilution and administration. Accidental mishandling therefore presents challenging clinical dilemmas, which often led vaccine providers to err on the side of caution and discard mishandled vials rather than risk administering ineffective vaccine. This study aims to answer key questions about the vaccine's stability to allow for a more informed decision-making process should a non-conformity occur. Residual vaccine in freshly used, but appropriately stored vials collected from vaccination centres in Brighton, UK, were tested after exposure to various handling conditions and analysed by dynamic light scattering to determine the size of the lipid-mRNA nanoparticles, and gel electrophoresis to visualise the mRNA integrity and separation from the lipid formulation. Knocking or dropping vaccine samples from small heights resulted in lowest levels of instability, indicating low risk of compromising clinical efficacy. However, repeated drawing and injecting through 23 G needles at high speed and, more significantly, shaking and vortexing led to progressive increase in the size and polydispersity index of the lipid-mRNA nanoparticles, coupled with or caused by up to ~50% release of mRNA from the lipid formulation. This is thought to impact the vaccine's efficacy due to lack of free mRNA protection and cellular internalisation. These results reiterate the importance of adhering to the manufacturer's instructions on handling, especially with regard to shaking and exposing the vaccine to excessive vibration.Keywords
This publication has 12 references indexed in Scilit:
- Opportunities and Challenges in the Delivery of mRNA-Based VaccinesPharmaceutics, 2020
- Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA VaccinesMolecular Therapy Nucleic Acids, 2019
- The discovery and enhanced properties of trichain lipids in lipopolyplex gene delivery systemsOrganic & Biomolecular Chemistry, 2018
- mRNA as novel technology for passive immunotherapyCellular and Molecular Life Sciences, 2018
- Trichain cationic lipids: the potential of their lipoplexes for gene deliveryBiomaterials Science, 2018
- mRNA vaccines — a new era in vaccinologyNature Reviews Drug Discovery, 2018
- Tools for translation: non-viral materials for therapeutic mRNA deliveryNature Reviews Materials, 2017
- Delivery of siRNA using ternary complexes containing branched cationic peptides: the role of peptide sequence, branching and targetingMolecular BioSystems, 2016
- Vaccine delivery: a matter of size, geometry, kinetics and molecular patternsNature Reviews Immunology, 2010
- The Many Pathways of RNA DegradationCell, 2009